FIELD: medicine; ophthalmology.
SUBSTANCE: cytostatic agent is subconjuctive introduced. Agent introduced is added with 0.08% trypan blue solution in amount 0.05 ml. Introduced agent localisation is visualised. In case agent becomes localized in anterior chamber or escapes through conjunctive suture introduction is stopped. In case agent spreads under conjunctiva dose in required amount is introduced.
EFFECT: lower rate of complications caused by cytostatics introduction.
2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PROLONGING THE NEEDLING RESULTS OF THE SCAR-MODIFIED FILTRATION PAD | 2019 |
|
RU2734050C1 |
SURGICAL TREATMENT METHOD OF GLAUCOMA | 2018 |
|
RU2693824C1 |
METHOD FOR PREVENTION OF INTER-TISSUE ADHESIONS AFTER FILTRATING ANTIGLAUCOMATOUS OPERATION | 2008 |
|
RU2369368C1 |
METHOD FOR STABILIZING INTRA-OCULAR PRESSURE IN POST-OPERATIONAL PERIOD IN CASE OF ANTIGLAUCOMATOUS OPERATIONS OF FILTERING TYPE | 2004 |
|
RU2281070C2 |
METHOD FOR TREATING GLAUCOMA | 1995 |
|
RU2086218C1 |
METHOD OF NEEDLING FOR CICATRISATION OF FILTERING BLEB AFTER ANTIGLAUCOMA OPERATIONS | 2024 |
|
RU2824290C1 |
SURGICAL METHOD FOR TREATING GLAUCOMA | 2000 |
|
RU2196555C2 |
METHOD OF TREATING SECONDARY GLAUCOMA CAUSED BY SILICONE EMULSIFICATION | 2013 |
|
RU2531133C1 |
METHOD FOR SURGICAL TREATMENT OF GLAUCOMA | 2004 |
|
RU2281073C2 |
METHOD FOR STABILIZING INTRAOCULAR PRESSURE IN POSTOPERATIVE PERIOD OF ANTIGLAUCOMATOUS OPERATIONS OF FILTRATING TYPE | 2002 |
|
RU2215504C1 |
Authors
Dates
2008-10-20—Published
2007-03-01—Filed